LGC Standards partners with PRIMACYT to improve access to hepatocytes for drug discovery research

LGC Standards partners with PRIMACYT to improve access to hepatocytes for drug discovery research Schwerin/Teddington, Middlesex: LGC Standards adds the PRIMACYT range of in-vitro products and services to its portfolio of life science research and drug discovery products.

PRIMACYT currently offers hepatocyte cells to the drug discovery research community throughout Europe and the partnership with LGC Standards will facilitate a wider distribution of these cells and allow greater access to these important in-vitro models. The drug development community recognises the need for improved in-vitro modelling systems and the collaboration between LGC - which holds the designated role as the UK's National Measurement Institute for chemical and bioanalytical measurement - and highly innovative companies such as PRIMACYT provides an ideal platform from which to develop new and more effective in-vitro systems and to facilitate their distribution. For more information see


About LGC Standards
LGC Standards (www.lgcstandards.com) provides products and services to improve measurement and quality control within the laboratory, and is part of LGC, whose LGC Science & Technology Division acts as the UK National Measurement Institute for chemical and bioanalytical measurements. LGC Standards supplies over 100,000 products, including reference materials, pharmaceutical impurity reference standards (produced under ISO Guide 34 accreditation), biological standards and reagents, and proficiency testing. LGC Standards is headquartered in Teddington, Middlesex, UK. Its global centre for excellence in proficiency testing is located in Bury (Greater Manchester).

About LGC
LGC is an international science-based company and market leader in analytical, forensic and diagnostic services and reference standards. LGC operates in a variety of markets which underpin the safety, health and security of the public and the regulation of industry, for both public and private sector clients.

PRIMACYT Cell Culture Technology GmbH, located in the technology and business park in Schwerin, provides services in the area of in-vitro technologies for pharmaceutical and biotech industry. Human and animal hepatocytes are offered as biosensoric assay systems for pharmacologic-toxicological analyses of drugs and for analysis of chemicals and environmental substances. With HEPAC2, the human hepatocyte cell culture system developed by PRIMACYT, clinical functional liver parameters in patients should be better predetermined than by animal studies. Since 2006 PRIMACYT offers studies in compliance with GLP, a quality control system demanded from international administration authorities for accreditation of newly developed drugs.

PRIMACYT Cell Culture Technology GmbH
Dieter Runge
Phone: +49 (0)385 3993 600
Fax: +49 (0)385 3993 602
Email: dieter.runge@primacyt.de